Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia

Clinical Chemistry - Tập 44 Số 5 - Trang 966-972 - 1998
Bent Raungaard1, Finn Heath1, Jens Uffe Brorholt‐Petersen1, Henrik Kjærulf Jensen2, Ole Færgeman1
1Department of Internal Medicine and Cardiology, Aarhus Amtssygehus University Hospital, DK-8000 Aarhus C, Denmark
2Department of Cardiology, Skejby Sygehus University Hospital, DK-8200 Aarhus N, Denmark

Tóm tắt

AbstractWe used a fluorescence flow cytometry assay with a monoclonal low density lipoprotein (LDL) receptor-specific antibody to detect LDL receptor expression on blood T lymphocytes and monocytes. We prepared peripheral blood mononuclear cells from patients with genetically verified LDL receptor-defective (Trp66-Gly mutation, n = 17) or receptor-negative (Trp23-stop mutation, n = 17) heterozygous familial hypercholesterolemia (FH) and from healthy individuals (n = 24). The cells were stimulated to express the maximum amount of LDL receptor by preincubation in lipoprotein-deficient medium. A dual-labeling technique allowed flow cytometric analysis of LDL receptor expression on cells identified by fluorescently conjugated surface marker antibodies. Knowing the LDL receptor gene mutation of the FH patients allowed us to compare the diagnostic capability of this functional assay with the DNA diagnosis and to validate the assay with molecular genetics instead of clinical indices of heterozygous FH. T lymphocytes expressed more LDL receptors and gave better diagnostic results than monocytes, and cells from patients with either the Trp66-Gly or the Trp23-stop mutation had variable but significantly reduced LDL receptor expression. The data indicate that this fluorescence flow cytometry assay is unsuitable for diagnosis of individual cases of heterozygous FH but that it may be useful for functionally characterizing mutations in the LDL receptor gene.

Từ khóa


Tài liệu tham khảo

1995, The metabolic basis of inherited disease, 1981

1979, Acta Paediatr Scand, 68, 541, 10.1111/j.1651-2227.1979.tb05052.x

1996, Atherosclerosis, 120, 57, 10.1016/0021-9150(95)05680-7

1992, Hum Mutat, 1, 445, 10.1002/humu.1380010602

1996, Clin Chem, 42, 1140, 10.1093/clinchem/42.8.1140

1982, J Biol Chem, 257, 7994, 10.1016/S0021-9258(18)34287-X

1983, Proc Natl Acad Sci U S A, 80, 3499, 10.1073/pnas.80.11.3499

1973, Proc Natl Acad Sci U S A, 70, 2162, 10.1073/pnas.70.7.2162

1974, J Biol Chem, 249, 5153, 10.1016/S0021-9258(19)42341-7

1978, J Clin Invest, 61, 678, 10.1172/JCI108980

1982, Metabolism, 31, 721, 10.1016/0026-0495(82)90204-9

1986, J Histochem Cytochem, 34, 1217, 10.1177/34.9.2426348

1993, Arterioscler Thromb, 13, 1053, 10.1161/01.ATV.13.7.1053

1995, Cytometry, 20, 290, 10.1002/cyto.990200404

1996, J Lipid Res, 37, 1363, 10.1016/S0022-2275(20)39166-5

1996, J Lipid Res, 37, 1377, 10.1016/S0022-2275(20)39168-9

1968, Scand J Clin Lab Invest, Suppl 97, 77

1992, Scand J Clin Lab Invest, Suppl 208, 13

1984, Scand J Clin Lab Invest, Suppl 172, 19

1981, J Biol Chem, 256, 11923, 10.1016/S0021-9258(19)68494-2

1976, J Clin Invest, 58, 1465, 10.1172/JCI108603

1986, N Engl J Med, 314, 879, 10.1056/NEJM198604033141404

1979, J Lipid Res, 20, 379, 10.1016/S0022-2275(20)40621-2

Thông tin
Thông tin xuất bản

Clinical Chemistry

Tập 44 Số 5

966-972

Thông tin tác giả